1
Reid W von Borstel: Compositions and methods for treatment of mitochondrial diseases. Pro Neuron, Nixon & Vanderhye, October 29, 2002: US06472378 (43 worldwide citation)

Compounds, compositions, and methods are provided for treatment of disorders related to mitochondrial dysfunction. The methods comprise administering to a mammal a composition containing pyrimidine nucleotide precursors in amounts sufficient to treat symptoms resulting from mitochondrial respiratory ...


2
Reid W von Borstel: Compositions and methods for treatment of mitochondrial diseases. Wellstat Therapeutics Coporation, Nixon & Vanderhye, October 18, 2005: US06956028 (5 worldwide citation)

Compounds, compositions, and methods are provided for treatment of disorders related to mitochondrial dysfunction. The methods comprise administering to a mammal a composition containing pyrimidine nucleotide precursors in amounts sufficient to treat symptoms resulting from mitochondrial respiratory ...


3
Reld W Von Borstel: Compositions and methods for treatment of mitochondrial diseases. Wellstat Therapeutics Corporation, Nixon & Vanderhye, March 29, 2011: US07915233 (1 worldwide citation)

Compounds, compositions, and methods are provided for treatment of disorders related to mitochondrial dysfunction. The methods comprise administering to a mammal a composition containing pyrimidien nucleotide precursors in amounts sufficient to treat symptoms resulting from mitochondrial respiratory ...


4
Reid W Von Borstel: Compositions and methods for treatment of mitochondrial diseases. Nixon & Vanderhye, June 28, 2001: US20010005719-A1 (1 worldwide citation)

Compounds, compositions, and methods are provided for treatment of disorders related to mitochondrial dysfunction. The methods comprise administering to a mammal a composition containing pyrimidine nucleotide precursors in amounts sufficient to treat symptoms resulting from mitochondrial respiratory ...


5
Reid W Von Borstel: Compositions and methods for treatment of mitochondrial diseases. Wellstat Therapeutics Corporation, Nixon & Vanderhye, November 29, 2011: US08067392

Compounds, compositions, and methods are provided for treatment of disorders related to mitochondrial dysfunction. The methods comprise administering to a mammal a composition containing pyrimidien nucleotide precursors in amounts sufficient to treat symptoms resulting from mitochondrial respiratory ...


6
Reid W Von Borstel, Joel A Saydoff: Compositions and methods for treatment of mitochondrial diseases. Wellstat Therapeutics Corporation, Nixon & Vanderhye PC, October 5, 2010: US07807654

Compounds, compositions, and methods are provided for treatment of disorders related to mitochondrial dysfunction. The methods comprise administering to a mammal a composition containing pyrimidine nucleotide precursors in amounts sufficient to treat symptoms resulting from mitochondrial respiratory ...


7
Reid W von Borstel: Compositions and methods for treatment of mitochondrial diseases. Wellstat Therapeutics Corporation, Nixon & Vanderhye, September 1, 2009: US07582619

Compounds, compositions, and methods are provided for treatment of disorders related to mitochondrial dysfunction. The methods comprise administering to a mammal a composition containing pyrimidine nucleotide precursors in amounts sufficient to treat symptoms resulting from mitochondrial respiratory ...


8
Von Borstel Reid W: Compositions and methods for treatment of mitochondrial diseases. Pro Neuron, June 27, 2001: EP1109453-A1

Compounds, compositions, and methods are provided for treatment of disorders related to mitochondrial dysfunction. The methods comprise administering to a mammal a composition containing pyrimidien nucleotide precursors in amounts sufficient to treat symptoms resulting from mitochondrial respiratory ...


9
Song Liu, Bingwei Lu: Compositions and methods for treatment of mitochondrial diseases. The Board of Trustees of the Leland Stanford Junior University, Bozicevic Field & Francis, David C Scherer, February 23, 2016: US09265788

Methods and compositions are provided for the treatment of a mitochondrial disease in an individual with the mitochondrial disease. Aspects of the methods include administering an inhibitor of a mitochondrial transport protein to a subject having a mitochondrial disease. Also provided are reagents a ...


10
Bingwei Lu, Stephan Gehrke: Methods of trans-differentiating a terminally differentiated target cell to a neuron. The Board of Trustees of the Leland Stanford Junior University, Bret E Field, Bozicevic Field & Francis, August 1, 2017: US09719090

Methods and compositions are provided for the treatment of a mitochondrial disease in an individual with the mitochondrial disease. Aspects of the methods include administering an inhibitor of a Pumilio-like protein and/or an inhibitor of a serine/arginine-rich family of pre-mRNA splicing factor (SR ...